SG11202109213RA - Process for preparing 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide - Google Patents
Process for preparing 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamideInfo
- Publication number
- SG11202109213RA SG11202109213RA SG11202109213RA SG11202109213RA SG11202109213RA SG 11202109213R A SG11202109213R A SG 11202109213RA SG 11202109213R A SG11202109213R A SG 11202109213RA SG 11202109213R A SG11202109213R A SG 11202109213RA SG 11202109213R A SG11202109213R A SG 11202109213RA
- Authority
- SG
- Singapore
- Prior art keywords
- acryloylpiperidin
- phenoxyphenyl
- nicotinamide
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962810305P | 2019-02-25 | 2019-02-25 | |
| PCT/CN2020/076387 WO2020173407A1 (en) | 2019-02-25 | 2020-02-24 | Process for preparing 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202109213RA true SG11202109213RA (en) | 2021-09-29 |
Family
ID=72238782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202109213RA SG11202109213RA (en) | 2019-02-25 | 2020-02-24 | Process for preparing 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210380555A1 (zh) |
| EP (1) | EP3931182A4 (zh) |
| JP (1) | JP2022521763A (zh) |
| KR (1) | KR20210131374A (zh) |
| CN (1) | CN113454066B (zh) |
| AU (1) | AU2020229919A1 (zh) |
| BR (1) | BR112021016787A2 (zh) |
| CA (1) | CA3131302A1 (zh) |
| MX (1) | MX2021010199A (zh) |
| SG (1) | SG11202109213RA (zh) |
| TW (1) | TWI830876B (zh) |
| WO (1) | WO2020173407A1 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115894440A (zh) * | 2022-10-27 | 2023-04-04 | 都创(重庆)医药科技有限公司 | 奥布替尼化合物的晶型及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2376765T3 (es) * | 2006-04-11 | 2012-03-16 | Vertex Pharmaceuticals, Inc. | Tiazoles, imidazoles y pirazoles útiles como inhibidores de proteína quinasas |
| KR102272792B1 (ko) * | 2013-09-30 | 2021-07-05 | 광저우 이노케어 파마 테크 씨오., 엘티디. | Ｂｔｋ의 치환된 니코틴이미드 저해제 및 그의 제조 방법 및 암, 염증 및 자가면역 질환에의 용도 |
| CN107226805A (zh) * | 2016-03-24 | 2017-10-03 | 北京天诚医药科技有限公司 | 芳香族酰胺类衍生物、其制备方法及其在医药上的应用 |
| EP3876911A4 (en) * | 2018-11-06 | 2022-06-22 | Beijing InnoCare Pharma Tech Co., Ltd. | AMORPHOUS SOLID DISPERSION WITH 6-(1-ACRYLOYLPIPERIDINE-4-YL)-2-(4-PHENOXYPHENYL)-NICOTINAMIDE |
-
2020
- 2020-02-24 MX MX2021010199A patent/MX2021010199A/es unknown
- 2020-02-24 CA CA3131302A patent/CA3131302A1/en active Pending
- 2020-02-24 WO PCT/CN2020/076387 patent/WO2020173407A1/en unknown
- 2020-02-24 JP JP2021549695A patent/JP2022521763A/ja active Pending
- 2020-02-24 KR KR1020217029894A patent/KR20210131374A/ko active Search and Examination
- 2020-02-24 CN CN202080015876.7A patent/CN113454066B/zh active Active
- 2020-02-24 BR BR112021016787A patent/BR112021016787A2/pt unknown
- 2020-02-24 AU AU2020229919A patent/AU2020229919A1/en active Pending
- 2020-02-24 EP EP20762224.2A patent/EP3931182A4/en active Pending
- 2020-02-24 SG SG11202109213RA patent/SG11202109213RA/en unknown
- 2020-02-25 TW TW109106065A patent/TWI830876B/zh active
-
2021
- 2021-08-20 US US17/407,340 patent/US20210380555A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3931182A1 (en) | 2022-01-05 |
| CA3131302A1 (en) | 2020-09-03 |
| JP2022521763A (ja) | 2022-04-12 |
| CN113454066A (zh) | 2021-09-28 |
| MX2021010199A (es) | 2021-09-21 |
| TW202031642A (zh) | 2020-09-01 |
| KR20210131374A (ko) | 2021-11-02 |
| AU2020229919A1 (en) | 2021-10-14 |
| EP3931182A4 (en) | 2023-01-25 |
| BR112021016787A2 (pt) | 2021-11-16 |
| US20210380555A1 (en) | 2021-12-09 |
| CN113454066B (zh) | 2024-02-09 |
| WO2020173407A1 (en) | 2020-09-03 |
| TWI830876B (zh) | 2024-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2541986B (en) | Communication paths for robot arms | |
| PL3199479T3 (pl) | Sposób przenoszenia artykułów | |
| EP3325443A4 (en) | PROCESS FOR PREPARING PRIDOPIDINE | |
| EP3321272A4 (en) | Method for preparing l-bpa | |
| PL3313341T3 (pl) | Sposoby przenoszenia oddzielnych wyrobów | |
| IL292429B1 (en) | An improved process for the preparation of aminopyrimidine derivatives | |
| EP3393972A4 (en) | PROCESS FOR THE PREPARATION OF IRON EXCHANGE ZEOLITE COMPOSITION (III) | |
| EP3276042A4 (en) | Method for producing plated article | |
| IL288593A (en) | Processes for the preparation of aminopyrimidine compounds | |
| ZA201807239B (en) | Method for preparing azoxystrobin | |
| SG11202109213RA (en) | Process for preparing 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide | |
| EP4055009C0 (en) | METHOD OF MANUFACTURING DEXMEDETOMIDINE | |
| SG11202103861YA (en) | Amorphous solid dispersion comprising 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide | |
| EP3243525A4 (en) | Method for treating anemia using long-acting epo preparation | |
| PL3090848T3 (pl) | Sposób obróbki płytowych przedmiotów obrabianych | |
| EP3652158A4 (en) | METHOD FOR PRODUCING A PYRIMIDONE COMPOUND | |
| IL288950A (en) | History of pyridine-3-yl | |
| PL3573988T3 (pl) | Sposób wytwarzania pochodnych puryny | |
| SG11202102116XA (en) | Crystalline forms of 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide | |
| IL282036A (en) | A process for the preparation of imidazole derivatives | |
| IL282034A (en) | A process for the preparation of modified imidazole derivatives | |
| IL263970B (en) | A method for the preparation of halogenated pyridine derivatives | |
| IL255256B (en) | A method for the preparation of 5-fluoro-h1-pyrazole-4-carbonyl fluorides | |
| EP3398959A4 (en) | METHOD OF PREPARING LIXISENNATIDE | |
| EP3392353A4 (en) | Method for manufacturing molten iron |